Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.

VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped...

Full description

Bibliographic Details
Main Authors: Blandine Patillon, Pierre Luisi, Hélène Blanché, Etienne Patin, Howard M Cann, Emmanuelle Génin, Audrey Sabbagh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3532425?pdf=render
id doaj-9e6d86977cab4257bbcca362cc407418
record_format Article
spelling doaj-9e6d86977cab4257bbcca362cc4074182020-11-24T20:49:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5304910.1371/journal.pone.0053049Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.Blandine PatillonPierre LuisiHélène BlanchéEtienne PatinHoward M CannEmmanuelle GéninAudrey SabbaghVKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1 and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations. Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK, MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain present-day differences among human populations in AVK dose requirement. Our results show that the extended region surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of genetically diverse populations in order to account for other neighboring and confounding selective events and the hitchhiking effect.http://europepmc.org/articles/PMC3532425?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Blandine Patillon
Pierre Luisi
Hélène Blanché
Etienne Patin
Howard M Cann
Emmanuelle Génin
Audrey Sabbagh
spellingShingle Blandine Patillon
Pierre Luisi
Hélène Blanché
Etienne Patin
Howard M Cann
Emmanuelle Génin
Audrey Sabbagh
Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
PLoS ONE
author_facet Blandine Patillon
Pierre Luisi
Hélène Blanché
Etienne Patin
Howard M Cann
Emmanuelle Génin
Audrey Sabbagh
author_sort Blandine Patillon
title Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
title_short Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
title_full Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
title_fullStr Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
title_full_unstemmed Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
title_sort positive selection in the chromosome 16 vkorc1 genomic region has contributed to the variability of anticoagulant response in humans.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1 and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations. Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK, MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain present-day differences among human populations in AVK dose requirement. Our results show that the extended region surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of genetically diverse populations in order to account for other neighboring and confounding selective events and the hitchhiking effect.
url http://europepmc.org/articles/PMC3532425?pdf=render
work_keys_str_mv AT blandinepatillon positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT pierreluisi positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT heleneblanche positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT etiennepatin positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT howardmcann positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT emmanuellegenin positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
AT audreysabbagh positiveselectioninthechromosome16vkorc1genomicregionhascontributedtothevariabilityofanticoagulantresponseinhumans
_version_ 1716805418430234624